143 related articles for article (PubMed ID: 16627978)
1. Proteomic analysis of hemangioblastoma cyst fluid.
Gläsker S; Vortmeyer AO; Lonser RR; Lubensky IA; Okamoto H; Xia JB; Li J; Milne E; Kowalak JA; Oldfield EH; Zhuang Z
Cancer Biol Ther; 2006 May; 5(5):549-53. PubMed ID: 16627978
[TBL] [Abstract][Full Text] [Related]
2. In vivo and ex vivo magnetic resonance spectroscopy in the characterization of hemangioblastoma cyst fluid.
Crisi G; Filice S; Pertinhez TA; Ventura E; Servadei F
J Comput Assist Tomogr; 2014; 38(1):29-32. PubMed ID: 24424553
[TBL] [Abstract][Full Text] [Related]
3. Edema is a precursor to central nervous system peritumoral cyst formation.
Lonser RR; Vortmeyer AO; Butman JA; Glasker S; Finn MA; Ammerman JM; Merrill MJ; Edwards NA; Zhuang Z; Oldfield EH
Ann Neurol; 2005 Sep; 58(3):392-9. PubMed ID: 16130092
[TBL] [Abstract][Full Text] [Related]
4. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
[TBL] [Abstract][Full Text] [Related]
5. Surgical management of cerebellar hemangioblastomas in patients with von Hippel-Lindau disease.
Jagannathan J; Lonser RR; Smith R; DeVroom HL; Oldfield EH
J Neurosurg; 2008 Feb; 108(2):210-22. PubMed ID: 18240914
[TBL] [Abstract][Full Text] [Related]
6. Effect of pregnancy on hemangioblastoma development and progression in von Hippel-Lindau disease.
Ye DY; Bakhtian KD; Asthagiri AR; Lonser RR
J Neurosurg; 2012 Nov; 117(5):818-24. PubMed ID: 22937928
[TBL] [Abstract][Full Text] [Related]
7. Recurrent cerebellar hemangioblastoma with enhancing tumor in the cyst wall: case report.
Bishop FS; Liu JK; Chin SS; Fults DW
Neurosurgery; 2008 Jun; 62(6):E1378-9; discussion E1379. PubMed ID: 18824960
[TBL] [Abstract][Full Text] [Related]
8. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
9. Metastases to hemangioblastomas in von Hippel-Lindau disease.
Jarrell ST; Vortmeyer AO; Linehan WM; Oldfield EH; Lonser RR
J Neurosurg; 2006 Aug; 105(2):256-63. PubMed ID: 17219831
[TBL] [Abstract][Full Text] [Related]
10. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
Stratmann R; Krieg M; Haas R; Plate KH
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
[TBL] [Abstract][Full Text] [Related]
11. GLUT1 immunoreaction patterns reliably distinguish hemangioblastoma from metastatic renal cell carcinoma.
North PE; Mizeracki A; Mihm MC; Mrak RE
Clin Neuropathol; 2000; 19(3):131-7. PubMed ID: 14606586
[TBL] [Abstract][Full Text] [Related]
12. Pathology, genetics and cell biology of hemangioblastomas.
Wizigmann-Voos S; Plate KH
Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
[TBL] [Abstract][Full Text] [Related]
13. Essentials and pitfalls in the treatment of CNS hemangioblastomas and von Hippel-Lindau disease.
Gläsker S; Klingler JH; Müller K; Würtenberger C; Hader C; Zentner J; Neumann HP; Velthoven VV
Cent Eur Neurosurg; 2010 May; 71(2):80-7. PubMed ID: 20229452
[TBL] [Abstract][Full Text] [Related]
14. Difference in CXCR4 expression between sporadic and VHL-related hemangioblastoma.
Kruizinga RC; van Marion DM; den Dunnen WF; de Groot JC; Hoving EW; Oosting SF; Timmer-Bosscha H; Derks RP; Cornelissen C; van der Luijt RB; Links TP; de Vries EG; Walenkamp AM
Fam Cancer; 2016 Oct; 15(4):607-16. PubMed ID: 26920352
[TBL] [Abstract][Full Text] [Related]
15. [Hemangioblastoma and von Hippel-Lindau disease].
Matsumoto K; Kannuki S
Nihon Rinsho; 1995 Nov; 53(11):2672-7. PubMed ID: 8538024
[TBL] [Abstract][Full Text] [Related]
16. Extraneuraxial hemangioblastoma: A clinicopathologic study of 10 cases with molecular analysis of the VHL gene.
Muscarella LA; Bisceglia M; Galliani CA; Zidar N; Ben-Dor DJ; Pasquinelli G; la Torre A; Sparaneo A; Fanburg-Smith JC; Lamovec J; Michal M; Bacchi CE
Pathol Res Pract; 2018 Aug; 214(8):1156-1165. PubMed ID: 29941223
[TBL] [Abstract][Full Text] [Related]
17. Developmental arrest of angioblastic lineage initiates tumorigenesis in von Hippel-Lindau disease.
Vortmeyer AO; Frank S; Jeong SY; Yuan K; Ikejiri B; Lee YS; Bhowmick D; Lonser RR; Smith R; Rodgers G; Oldfield EH; Zhuang Z
Cancer Res; 2003 Nov; 63(21):7051-5. PubMed ID: 14612494
[TBL] [Abstract][Full Text] [Related]
18. von Hippel-Lindau gene deletion detected in the stromal cell component of a cerebellar hemangioblastoma associated with von Hippel-Lindau disease.
Vortmeyer AO; Gnarra JR; Emmert-Buck MR; Katz D; Linehan WM; Oldfield EH; Zhuang Z
Hum Pathol; 1997 May; 28(5):540-3. PubMed ID: 9158701
[TBL] [Abstract][Full Text] [Related]
19. Aquaporin 1 expression in cystic hemangioblastomas.
Longatti P; Basaldella L; Orvieto E; Dei Tos AP; Martinuzzi A
Neurosci Lett; 2006 Jan; 392(3):178-80. PubMed ID: 16300893
[TBL] [Abstract][Full Text] [Related]
20. Propranolol reduces viability and induces apoptosis in hemangioblastoma cells from von Hippel-Lindau patients.
Albiñana V; Villar Gómez de Las Heras K; Serrano-Heras G; Segura T; Perona-Moratalla AB; Mota-Pérez M; de Campos JM; Botella LM
Orphanet J Rare Dis; 2015 Sep; 10():118. PubMed ID: 26394686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
